TipRanks
Sanofi (IT:1SAN)
:1SAN
Italy Market

Sanofi (1SAN) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

1SAN Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
6 Buy
6 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Sanofi
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1SAN Stock 12 Month Forecast

Average Price Target

€93.82
▲(21.44% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is €93.82 with a high forecast of €106.21 and a low forecast of €80.00. The average price target represents a 21.44% change from the last price of €77.26.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"72":"€72","107":"€107","80.75":"€80.8","89.5":"€89.5","98.25":"€98.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":106.21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€106.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":93.821,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€93.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€80.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[72,80.75,89.5,98.25,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.24,75.77615384615385,78.31230769230768,80.84846153846154,83.38461538461539,85.92076923076922,88.45692307692308,90.99307692307693,93.52923076923076,96.0653846153846,98.60153846153845,101.1376923076923,103.67384615384614,{"y":106.21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.24,74.82315384615384,76.40630769230769,77.98946153846154,79.57261538461537,81.15576923076922,82.73892307692307,84.32207692307692,85.90523076923077,87.48838461538462,89.07153846153847,90.6546923076923,92.23784615384615,{"y":93.821,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.24,73.75999999999999,74.28,74.8,75.32,75.84,76.36,76.88,77.39999999999999,77.92,78.44,78.96,79.48,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":80.543,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.196,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.926,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.667,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.384,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.218,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.459,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.731,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.09,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.06,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.16,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.97,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.24,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€106.21Average Price Target€93.82Lowest Price Target€80.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on IT:1SAN
Bank of America Securities
Bank of America Securities
€92
Hold
19.08%
Upside
Reiterated
10/08/26
Analysts Conflicted on These Healthcare Names: Sanofi (Other OTC: SNYNF), Arvinas Holding Company (NASDAQ: ARVN) and Halozyme (NASDAQ: HALO)
J.P. Morgan Analyst forecast on IT:1SAN
J.P. Morgan
J.P. Morgan
€95
Hold
22.96%
Upside
Reiterated
10/07/26
J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Jefferies
€100
Buy
29.43%
Upside
Reiterated
10/07/26
Sanofi (SNYNF) Gets a Buy from Jefferies
Berenberg Bank Analyst forecast on IT:1SAN
Berenberg Bank
Berenberg Bank
€105
Buy
35.90%
Upside
Reiterated
10/05/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Option Care Health (NASDAQ: OPCH)
RBC Capital Analyst forecast on IT:1SAN
RBC Capital
RBC Capital
€80
Hold
3.55%
Upside
Reiterated
10/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Eli Lilly & Co (NYSE: LLY)
Deutsche Bank  Analyst forecast on IT:1SAN
Deutsche Bank
Deutsche Bank
€95
Buy
22.96%
Upside
Reiterated
09/29/26
Sanofi (SNYNF) Receives a Buy from Deutsche Bank
UBS
―
Hold
―
Reiterated
09/17/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Amgen (NASDAQ: AMGN) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
HSBC
€95→€100
Buy
29.43%
Upside
Reiterated
09/10/26
Sanofi price target raised to EUR 100 from EUR 95 at HSBCSanofi price target raised to EUR 100 from EUR 95 at HSBC
Barclays
€79→€83
Hold
7.43%
Upside
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Merck & Company (NYSE: MRK)
Morgan Stanley Analyst forecast on IT:1SAN
Morgan Stanley
Morgan Stanley
€86→€82
Hold
6.14%
Upside
Reiterated
08/11/26
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
Bernstein Analyst forecast on IT:1SAN
Bernstein
Bernstein
€107→€106.21
Buy
37.47%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
DZ BANK AG Analyst forecast on IT:1SAN
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
07/31/26
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)
Goldman Sachs Analyst forecast on IT:1SAN
Goldman Sachs
Goldman Sachs
€89→€84
Hold
8.72%
Upside
Reiterated
07/06/26
Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)
Kepler Capital  Analyst forecast on IT:1SAN
Kepler Capital
Kepler Capital
€85
Hold
10.02%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)
Citi
€85→€80
Hold
3.55%
Upside
Reiterated
02/20/26
Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on IT:1SAN
Bank of America Securities
Bank of America Securities
€92
Hold
19.08%
Upside
Reiterated
10/08/26
Analysts Conflicted on These Healthcare Names: Sanofi (Other OTC: SNYNF), Arvinas Holding Company (NASDAQ: ARVN) and Halozyme (NASDAQ: HALO)
J.P. Morgan Analyst forecast on IT:1SAN
J.P. Morgan
J.P. Morgan
€95
Hold
22.96%
Upside
Reiterated
10/07/26
J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Jefferies
€100
Buy
29.43%
Upside
Reiterated
10/07/26
Sanofi (SNYNF) Gets a Buy from Jefferies
Berenberg Bank Analyst forecast on IT:1SAN
Berenberg Bank
Berenberg Bank
€105
Buy
35.90%
Upside
Reiterated
10/05/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Option Care Health (NASDAQ: OPCH)
RBC Capital Analyst forecast on IT:1SAN
RBC Capital
RBC Capital
€80
Hold
3.55%
Upside
Reiterated
10/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Eli Lilly & Co (NYSE: LLY)
Deutsche Bank  Analyst forecast on IT:1SAN
Deutsche Bank
Deutsche Bank
€95
Buy
22.96%
Upside
Reiterated
09/29/26
Sanofi (SNYNF) Receives a Buy from Deutsche Bank
UBS
―
Hold
―
Reiterated
09/17/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Amgen (NASDAQ: AMGN) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
HSBC
€95→€100
Buy
29.43%
Upside
Reiterated
09/10/26
Sanofi price target raised to EUR 100 from EUR 95 at HSBCSanofi price target raised to EUR 100 from EUR 95 at HSBC
Barclays
€79→€83
Hold
7.43%
Upside
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Merck & Company (NYSE: MRK)
Morgan Stanley Analyst forecast on IT:1SAN
Morgan Stanley
Morgan Stanley
€86→€82
Hold
6.14%
Upside
Reiterated
08/11/26
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
Bernstein Analyst forecast on IT:1SAN
Bernstein
Bernstein
€107→€106.21
Buy
37.47%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
DZ BANK AG Analyst forecast on IT:1SAN
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
07/31/26
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)
Goldman Sachs Analyst forecast on IT:1SAN
Goldman Sachs
Goldman Sachs
€89→€84
Hold
8.72%
Upside
Reiterated
07/06/26
Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)
Kepler Capital  Analyst forecast on IT:1SAN
Kepler Capital
Kepler Capital
€85
Hold
10.02%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)
Citi
€85→€80
Hold
3.55%
Upside
Reiterated
02/20/26
Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
IMUXImmunic
REPLReplimune Group
OVIDOvid Therapeutics
CELCCelcuity
ARDXArdelyx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sanofi

3 Months
David RisingerLeerink Partners
Success Rate
19/35 ratings generated profit
54%
Average Return
-0.30%
Copying David Risinger's trades and holding each position for 3 Months would result in 54.29% of your transactions generating a profit, with an average return of -0.30% per trade.
1 Year
David RisingerLeerink Partners
Success Rate
20/35 ratings generated profit
57%
Average Return
+2.16%
Copying David Risinger's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.16% per trade.
2 Years
Emmanuel PapadakisDeutsche Bank
Success Rate
22/55 ratings generated profit
40%
Average Return
-3.31%
Copying Emmanuel Papadakis's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -3.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1SAN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
10
10
14
15
13
Hold
9
12
13
17
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
22
27
32
24
In the current month, 1SAN has received 13 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. 1SAN average Analyst price target in the past 3 months is 93.82.
Each month's total comprises the sum of three months' worth of ratings.

1SAN Financial Forecast

1SAN Earnings Forecast

Next quarter’s earnings estimate for 1SAN is €2.78 with a range of €2.66 to €2.86. The previous quarter’s EPS was €2.09. 1SAN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1SAN has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1SAN is €2.78 with a range of €2.66 to €2.86. The previous quarter’s EPS was €2.09. 1SAN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1SAN has Performed in-line its overall industry.

1SAN Sales Forecast

Next quarter’s sales forecast for 1SAN is €13.68B with a range of €13.10B to €14.08B. The previous quarter’s sales results were €22.11B. 1SAN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1SAN has Performed in-line its overall industry.
Next quarter’s sales forecast for 1SAN is €13.68B with a range of €13.10B to €14.08B. The previous quarter’s sales results were €22.11B. 1SAN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1SAN has Performed in-line its overall industry.

1SAN Stock Forecast FAQ

What is IT:1SAN’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is 93.82.
    What is IT:1SAN’s upside potential, based on the analysts’ average price target?
    Sanofi has 21.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sanofi a Buy, Sell or Hold?
          Sanofi has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.
            What is Sanofi’s share price target?
            The average share price target for Sanofi is 93.82. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €106.21 ,and the lowest forecast is €80.00. The average share price target represents 21.44% Increase from the current price of €77.26.
              What do analysts say about Sanofi?
              Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Sanofi?
                To buy shares of IT:1SAN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.